We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

UCB (Pharma) Ireland Limited

United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
Telephone: + 353 14637395
Medical Information Direct Line: +353 1 463 2371
Medical Information e-mail: UCBCares.IE@ucb.com
Patient Information Leaflet last updated on medicines.ie: 11/13/2017
PIL Xyzal 5mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/13/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
Updated on 1/11/2017 and displayed until 11/13/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product contains
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
Updated on 5/23/2016 and displayed until 1/11/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 2/21/2013 and displayed until 5/23/2016
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 10/1/2009 and displayed until 2/21/2013
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 11/2/2007 and displayed until 10/1/2009
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 8/21/2007 and displayed until 11/2/2007
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 8/10/2007 and displayed until 8/21/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 8/10/2007 and displayed until 8/10/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 8/10/2007 and displayed until 8/10/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 8/10/2007 and displayed until 8/10/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 7/19/2005 and displayed until 8/10/2007
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Levocetirizine dihydrochloride